Pasithea Therapeutics Corp. Common Stock
€0.59288
EUR
Last updated on --.
24h volume133.90K
24h highest0.60755 EUR
24h lowest0.58511 EUR
24h Price movement+1.02%
KTTA recent prices
24 Hours
+1.02%+€0.0059547
30 days
+1.91%+€0.011133
60 days
-3.92%-€0.024164
90 days
-22.07%-€0.16794
Key data
Previous close0.58693 EUR
Market cap15.54M EUR
Volume133.90K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.68177 EUR
Net income (FY)-17.03M EUR
Revenue (FY)--
Last report date15 May 2026
About Pasithea Therapeutics Corp. Common Stock
HeadquartersMIAMI BEACH
Employees (FY)5.00
Net income per employee (FY)-3.41M EUR
Listed onNasdaq
KTTA conversion tables
 |  |
|---|---|
| 0.5 KTTA | 0.29644 EUR |
| 1 KTTA | 0.59288 EUR |
| 5 KTTA | 2.964 EUR |
| 10 KTTA | 5.928 EUR |
| |
|---|---|
| 0.5 EUR | 0.84334 KTTA |
| 1 EUR | 1.686 KTTA |
| 5 EUR | 8.433 KTTA |
| 10 EUR | 16.86 KTTA |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
KTTA is trading at €0.59288, +1.02% over the last 24 hours. Track live moves on the price chart at the top of this page.
The KTTA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. KTTA is currently trading at €0.59288, +1.02% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on KTTA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. KTTA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from KTTA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against KTTA's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Pasithea Therapeutics Corp. Common Stock's market cap is currently 15.54M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume133.90K
24h highest0.60755 EUR
24h lowest0.58511 EUR
24h Price movement+1.02%
Start trade with KTTA Perpetual
Sign up to trade